Chronic wounds "must be addressed in DMP" (disease management programme):
This article was originally published in Clinica
More attention must be paid to the treatment of open wounds in the German government's disease management programme (DMP) for diabetes mellitus type 2, says the medical device industry association, BVMed. The statement comes in response to the ministry of health's legislation on pre-requisites necessary to set up structured treatment programmes for the disease, published last month. BVMed estimates that the treatment of chronic wounds amounts to 25% of overall diabetes treatment costs. Some 4 million patients suffer from chronic wounds in Germany, and approximately 1 million of them are diabetics.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.